A tetra-primer amplification refractory mutation system-polymerase chain reaction for the detection of rs8099917 IL28B genotype

Nucleosides, Nucleotides and Nucleic Acids

Volumn 31, Issue 1, 2012, Pages 55-60

  Hashemi, Mohammad ^a,b   Moazeni Roodi, Abdolkarim ^c   Bahari, Ali ^d   Taheri, Mohsen ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IL28B; interferon lambda 3; Iranian; NAFLD; single nucleotide polymorphism; tetra ARMS PCR

Indexed keywords

ARTICLE; COMPARATIVE STUDY; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKINS; LIVER; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

HEPATITIS C VIRUS; TETRA;

EID: 84856854726     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.643846     Document Type: Article

References (18)

1. Witte, K.; Witte, E.; Sabat, R.; Wolk, K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev. 2010, 21(4), 237-251.
2. Zhang, L.; Jilg, N.; Shao, R.X.; Lin, W.; Fusco, D.N.; Zhao, H.; Goto, K.; Peng, L.F.; Chen, W.C.; Chung, R.T. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J. Hepatol. 2011, 55(2), 289-298.
3. Ge, D.; Fellay, J.; Thompson, A.J.; Simon, J.S.; Shianna, K.V.; Urban, T.J.; Heinzen, E.L.; Qiu, P.; Bertelsen, A.H.; Muir, A.J.; Sulkowski, M.; McHutchison, J.G.; Goldstein, D.B. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461(7262), 399-401.
4. Suppiah, V.; Moldovan, M.; Ahlenstiel, G.; Berg, T.; Weltman, M.; Abate, M.L.; Bassendine, M.; Spengler, U.; Dore, G.J.; Powell, E.; Riordan, S.; Sheridan, D.; Smedile, A.; Fragomeli, V.; Muller, T.; Bahlo, M.; Stewart, G.J.; Booth, D.R.; George, J. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet. 2009, 41(10), 1100-1104.
5. Tanaka, Y.; Nishida, N.; Sugiyama, M.; Kurosaki, M.; Matsuura, K.; Sakamoto, N.; Nakagawa, M.; Korenaga, M.; Hino, K.; Hige, S.; Ito, Y.; Mita, E.; Tanaka, E.; Mochida, S.; Murawaki, Y.; Honda, M.; Sakai, A.; Hiasa, Y.; Nishiguchi, S.; Koike, A.; Sakaida, I.; Imamura, M.; Ito, K.; Yano, K.; Masaki, N.; Sugauchi, F.; Izumi, N.; Tokunaga, K.; Mizokami, M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 2009, 41(10), 1105-1109.
6. Thomas, D.L.; Thio, C.L.; Martin, M.P.; Qi, Y.; Ge, D.; O'Huigin, C.; Kidd, J.; Kidd, K.; Khakoo, S.I.; Alexander, G.; Goedert, J.J.; Kirk, G.D.; Donfield, S.M.; Rosen, H.R.; Tobler, L.H.; Busch, M.P.; McHutchison, J.G.; Goldstein, D.B.; Carrington, M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461(7265), 798-801.
7. Thompson, A.J.; Muir, A.; Sulkowski, M.S.; Afdhal, N.H.; Jacobson, I.M.; Esteban, R.; Poordad, F.; McCone, J.; Shiffman, M.L.; Galler, G.; Lee, W.M.; Reindollar, R.; King, J.W.; Kwo, P.Y.; Ghalib, R.H.; Freilich, B.; Nyberg, L.M.; Patel, K.; Tillmann, H.L.; Noviello, S.; Koury, K.; Pedicone, L.; Brass, C.A.; Albrecht, J.K.; Goldstein, D.B.; McHutchison, J.G. Genome wide analysis of patients from the ideal study identifies a polymorphism upstream of the Il28b (Ifn lambda-3) gene that is strongly associated with Svr in patients with Hcv-1. Hepatology 2009, 50(6), 4A-5A.
8. Yu, M.L.; Huang, C.F.; Huang, J.F.; Chang, N.C.; Yang, J.F.; Lin, Z.Y.; Chen, S.C.; Hsieh, M.Y.; Wang, L.Y.; Chang, W.Y.; Li, Y.N.; Wu, M.S.; Dai, C.Y.; Juo, S.H.; Chuang, W.L. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology 2011, 53(1), 7-13.
9. Stattermayer, A.F.; Stauber, R.; Hofer, H.; Rutter, K.; Beinhardt, S.; Scherzer, T.M.; Zinober, K.; Datz, C.;Maieron, A.; Dulic-Lakovic, E.; Kessler, H.H.; Steindl-Munda, P.; Strasser, M.; Krall, C.; Ferenci, P. Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin. Gastroenterol. Hepatol. 2011, 9(4), 344-350, e342.
10. Scott, J.;Holte, S.;Urban, T.; Burgess, C.; Coppel, E.; Wang, C.; Corey, L.; McHutchison, J.; Goldstein, D. IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection. J. Infect. Dis. 2011, 204(3), 419-425.
11. Sarrazin, C.; Susser, S.; Doehring, A.; Lange, C.M.; Muller, T.; Schlecker, C.; Herrmann, E.; Lotsch, J.; Berg, T. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J. Hepatol. 2011, 54(3), 415-421.
12. Ruiz-Extremera, A.;Munoz-Gamez, J.A.; Salmeron-Ruiz, M.A.; de Rueda, P.M.; Quiles-Perez, R.; Gila-Medina, A.; Casado, J.; Belen Martin, A.; Sanjuan-Nunez, L.; Carazo, A.; Pavon, E.J.; Ocete-Hita, E.; Leon, J.; Salmeron, J. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology 2011, 53(6), 1830-1838.
13. Honda, M.; Sakai, A.; Yamashita, T.; Nakamoto, Y.; Mizukoshi, E.; Sakai, Y.; Nakamura, M.; Shirasaki, T.; Horimoto, K.; Tanaka, Y.; Tokunaga, K.; Mizokami, M.; Kaneko, S. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 2010, 139(2), 499-509.
14. Hashemi, M.; Hoseini, H.; Yaghmaei, P.;Moazeni-Roodi, A.; Bahari, A.; Hashemzehi, N.; Shafieipour, S. Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell. Biol. 2011, 30(8), 569-575.
15. Hashemi, M.; Moazeni-Roodi, A.K.; Fazaeli, A.; Sandoughi, M.; Bardestani, G.R.; Kordi-Tamandani, D.M.; Ghavami, S. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet. Mol. Res. 2010, 9(1), 333-339.
16. Hashemi, M.; Moazeni-Roodi, A.K.; Fazaeli, A.; Sandoughi, M.; Taheri, M.; Bardestani, G.R.; Zakeri, Z.; Kordi-Tamandani, D.M.; Ghavami, S. The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis. Genet. Mol. Res. 2010, 9(3), 1735-1741.
17. Ye, S.; Dhillon, S.; Ke, X.; Collins, A.R.; Day, I.N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res. 2001, 29(17), E88.
18. Balagopal, A.; Thomas, D.L.; Thio, C.L. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010, 139(6), 1865-1876.